Search results for " elastography"

showing 2 items of 82 documents

Liver stiffness quantification in biopsy-proven nonalcoholic fatty liver disease patients using shear wave elastography in comparison with transient …

2021

Purpose: This study prospectively assessed the performance of liver stiffness measurements using point shear-wave elastography (p-SWE) in comparison with transient elastography (TE) in patients with biopsy-proven nonalcoholic fatty liver disease (NAFLD). Methods: Fifty-six consecutive adult patients with a histological diagnosis of NAFLD prospectively underwent TE and p-SWE on the same day. The median of 10 measurements (SWE-10), the first five (SWE-5), and the first three (SWE-3) measurements were analyzed for p-SWE. Liver biopsy was considered as the reference standard for liver fibrosis grade. Receiver operating characteristic (ROC) curves and areas under the ROC curves (AUROCs) were cal…

nonalcoholic fatty liver diseasemedicine.medical_specialtyGastroenterologySettore MED/01 - Statistica Medica030218 nuclear medicine & medical imaging03 medical and health sciences0302 clinical medicineLiver stiffnessInternal medicineStatistical significanceBiopsyNonalcoholic fatty liver diseaseMedical technologymedicineRadiology Nuclear Medicine and imagingnonalcoholic steatohepatitisR855-855.5shear wave elastographymedicine.diagnostic_testReceiver operating characteristicbusiness.industryNonalcoholic fatty liver disease Nonalcoholic steatohepatitis Shear wave elastography Transient elastography Liver stiffnessmedicine.diseasetransient elastographyliver stiffnessLiver biopsyOriginal Article030211 gastroenterology & hepatologyElastographySettore MED/36 - Diagnostica Per Immagini E RadioterapiabusinessTransient elastographyUltrasonography
researchProduct

Two-Tier Care Pathways for Liver Fibrosis Associated to Non-Alcoholic Fatty Liver Disease in HIV Mono-Infected Patients.

2022

(1) Background: Developing strategies to identify significant liver fibrosis in people with HIV (PWH) is crucial to prevent complications of non-alcoholic fatty liver disease (NAFLD). We aim to investigate if five simple serum biomarkers applied to PWH can optimize a care pathway to identify significant liver fibrosis defined by transient elastography (TE). (2) Methods: A two-tier fibrosis pathway was applied to three prospective cohorts of PWH undergoing TE with CAP. NAFLD was diagnosed as a controlled attenuation parameter ≥ 248 dB/m. Five simple fibrosis biomarkers (FIB-4 < 1.3, BARD score 0–1, NAFLD fibrosis score < −1.455, AST:ALT ratio < 0.8 and APRI < 0.5) …

serum fibrosis biomarkertransient elastography.FIB-4Medicine (miscellaneous)transient elastography; controlled attenuation parameter; serum fibrosis biomarkers; APRI; FIB-4controlled attenuation parameterAPRIJournal of personalized medicine
researchProduct